Credit Agricole’s Immunogen Inc IMGN Stock Holding History

Credit Agricole’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-36,300	Closed	-$239K	–	747
2021 Q2	$239K	Hold	36,300	–	–	﹤0.01%	339
2021 Q1	$294K	Buy	36,300 +18,000	+98%	+$147K	0.01%	303
2020 Q4	$118K	Buy	18,300 +4,800	+36%	+$28K	﹤0.01%	344
2020 Q3	$49K	Hold	13,500	–	–	﹤0.01%	367
2020 Q2	$62K	Hold	13,500	–	–	﹤0.01%	313
2020 Q1	$46K	Buy	13,500 +3,500	+35%	+$15.3K	﹤0.01%	323
2019 Q4	$51K	Hold	10,000	–	–	﹤0.01%	312
2019 Q3	$24K	Hold	10,000	–	–	﹤0.01%	413
2019 Q2	$22K	Hold	10,000	–	–	﹤0.01%	418
2019 Q1	$27K	Buy	+10,000	New	+$43.3K	﹤0.01%	409
2017 Q3	–	Sell	-26,000	Closed	-$185K	–	1462
2017 Q2	$185K	Hold	26,000	–	–	﹤0.01%	1311
2017 Q1	$101K	Hold	26,000	–	–	﹤0.01%	1568
2016 Q4	$53K	Hold	26,000	–	–	﹤0.01%	1411
2016 Q3	$70K	Hold	26,000	–	–	﹤0.01%	1535
2016 Q2	$80K	Buy	+26,000	New	+$163K	﹤0.01%	1422

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Credit Agricole's IMGN Position: Q3 2021 in Review

Credit Agricole sold out of Immunogen Inc (IMGN) in Q3 2021, closing a stake of 36,300 shares — an estimated $239K sold.

Credit Agricole first reported a position in IMGN in Q2 2016 and held it in 15 quarters. The position peaked at $294K in Q1 2021. 217 funds tracked by Wall St. Rank hold IMGN as of Q3 2021.

Credit Agricole reported no remaining Immunogen Inc position as of Q3 2021 after selling out during the quarter.
Credit Agricole sold 36,300 Immunogen Inc shares in Q3 2021, an estimated $239K.
Credit Agricole first reported a position in Immunogen Inc in Q2 2016 and held it in 15 quarters.
Credit Agricole's Immunogen Inc position peaked at $294K in Q1 2021.
217 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2021.

Based on Credit Agricole's 13F filing for Q3 2021, filed 15 Nov 2021.